RNS Number : 2382C
Hikma Pharmaceuticals Plc
11 April 2017
 

 

Hikma Pharmaceuticals PLC - Vesting of 2014 EIP

 

LONDON, 11 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 10 April 2017 under the 2014 Executive Incentive Plan ("EIP") which was completed on 11 April 2017. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the EIP is £nil. As indicated in the table below, certain PDMRs have made disposals.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Khalid Nabilsi

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP).

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 14,165

d)

Aggregated information

N/A

e)

Date of the transaction

10 April 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Riad Mishlawi

2

Reason for the notification

a)

Position/status

EU Vice President and Global Head of Injectables

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP).

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 13,811

d)

Aggregated information

N/A

e)

Date of the transaction

10 April 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

                                                                 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Raya

2

Reason for the notification

a)

Position/status

CEO of West-Ward Pharmaceuticals

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired and disposed from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP). 7,902 shares were sold to cover tax and associated costs and 11,753 shares were retained.

c)

Price(s) and volume(s)

Price

Volume(s)

£19.42

7,902

£0.00

11,753

d)

Aggregated information

£20.00

£158,040

e)

Date of the transaction

10 April 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bassam Kanaan

2

Reason for the notification

a)

Position/status

Chief Strategy and Corporate Development Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP).

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 19,945

d)

Aggregated information

N/A

e)

Date of the transaction

10 April 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Majda Labadi

2

Reason for the notification

a)

Position/status

Corporate Vice President for Human Resources and Head of Operations, MENA

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from vesting of the conditional awards on 10 April 2017 under the 2014 Executive Incentive Plan (EIP).

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 10,089

d)

Aggregated information

N/A

e)

Date of the transaction

10 April 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

                                                     



 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBUGDSGGBBGRB